Vitamin D Tied to Falls, Nonmotor Symptoms in Parkinson Disease
No association seen between bone mineral density, vitamin D in patients with Parkinson disease.
Parkinson Disease
Parkinson Disease Risk Increased in Bipolar Disorder
More frequent manic/mixed and depressive episodes were associated with an increased risk for Parkinson disease.
Parkinson Disease Incidence Lower in Hep C Patients Who Receive Antivirals
Advantage of interferon-based antiviral therapy reached statistical significance at 5-year follow-up.
Incidence of Parkinson Disease Increased in Bipolar Disorder
High frequency of psychiatric admissions for manic/mix, depressive episodes linked to increased risk for PD.
Inhaled Levodopa Effectively Maintains ON State in Parkinson Disease
Extension study showed that levodopa inhalation powder maintained its efficacy in achieving an ON state in patients with Parkinson disease experiencing OFF periods.
Anxiety, Depression Associated With Levodopa-Responsive Freezing of Gait in Parkinson Disease
Depression and anxiety are associated with levodopa-responsive freezing of gait in patients with Parkinson disease.
Pimavanserin and Quetiapine Comparable for Psychosis in Parkinson Disease
There were no significant differences between pimavanserin and quetiapine in time to discontinuation, mortality, or improvement in psychosis in patients with Parkinson disease and Lewy body dementia.
Mindfulness Yoga Aids Patients With Parkinson Disease
Effects similar to those of stretching and resistance training for motor dysfunction, mobility.
Inbrija Now Available for On-Demand Use for OFF Periods in Patients With Parkinson Disease
Inbrija, the first inhaled levodopa, has been made available by Acorda Therapeutics for the intermittent treatment of OFF episodes in patients with Parkinson disease treated with carbidopa/levodopa.
Parkinson Disease Treatment Soon to Be Discontinued
Requip and Requip XL are non-ergot dopamine agonists indicated for the treatment of Parkinson disease.
Next post in Neurology Information Center
